DK96286A - 6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf - Google Patents
6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf Download PDFInfo
- Publication number
- DK96286A DK96286A DK96286A DK96286A DK96286A DK 96286 A DK96286 A DK 96286A DK 96286 A DK96286 A DK 96286A DK 96286 A DK96286 A DK 96286A DK 96286 A DK96286 A DK 96286A
- Authority
- DK
- Denmark
- Prior art keywords
- carbon atoms
- straight
- chain
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15504584A JPS6133173A (ja) | 1984-07-25 | 1984-07-25 | アミジン化合物 |
JP15504584 | 1984-07-25 | ||
JP8500392 | 1985-07-12 | ||
PCT/JP1985/000392 WO1986000893A1 (en) | 1984-07-25 | 1985-07-12 | Novel amidine compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
DK96286A true DK96286A (da) | 1986-03-03 |
DK96286D0 DK96286D0 (da) | 1986-03-03 |
DK169069B1 DK169069B1 (da) | 1994-08-08 |
Family
ID=15597463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK096286A DK169069B1 (da) | 1984-07-25 | 1986-03-03 | 6-Amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf |
Country Status (19)
Country | Link |
---|---|
US (2) | US4777182A (da) |
EP (1) | EP0190356B1 (da) |
JP (1) | JPS6133173A (da) |
KR (2) | KR870001087B1 (da) |
AU (1) | AU567039B2 (da) |
CA (1) | CA1254205A (da) |
CS (1) | CS255891B2 (da) |
DD (1) | DD235637A5 (da) |
DE (1) | DE3582057D1 (da) |
DK (1) | DK169069B1 (da) |
ES (1) | ES8607218A1 (da) |
FI (1) | FI78461C (da) |
HU (1) | HU195769B (da) |
MX (1) | MX160912A (da) |
NO (1) | NO163954C (da) |
PH (1) | PH20585A (da) |
SU (1) | SU1456008A3 (da) |
WO (1) | WO1986000893A1 (da) |
ZA (1) | ZA855552B (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3824236C1 (da) * | 1988-07-16 | 1989-12-28 | Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De | |
CA2032420A1 (en) * | 1989-12-22 | 1991-06-23 | Akira Okuyama | Guanidinobenzene derivatives |
US5238964A (en) * | 1990-04-05 | 1993-08-24 | Torii & Co., Ltd. | Agent for treatment of cerebrovascular contraction |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
CA2208032C (en) * | 1995-01-05 | 2003-12-23 | Torii Pharmaceutical Co., Ltd. | Substituted amidinonaphthyl ester derivative |
US5932603A (en) * | 1995-01-05 | 1999-08-03 | Torii Pharmaceutical Co., Ltd. | Thrombolytic agents |
CN1203846C (zh) | 1998-03-19 | 2005-06-01 | 布里斯托尔-迈尔斯斯奎布公司 | 高溶解性药物的双相控释递送系统和方法 |
WO2001077082A1 (fr) * | 1999-06-02 | 2001-10-18 | Torii Pharmaceutical Co., Ltd. | Derives de naphtalene |
AU2000252458A1 (en) * | 2000-06-08 | 2001-12-17 | Shizuoka Coffein Co., Ltd. | Benzene derivatives |
DE602006020434D1 (de) * | 2005-05-17 | 2011-04-14 | Santen Pharmaceutical Co Ltd | Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor |
US20090088472A1 (en) * | 2005-05-17 | 2009-04-02 | Kouji Oohashi | Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient |
US20100063146A1 (en) * | 2006-11-07 | 2010-03-11 | Medof M Edward | Method for treating disorders related to complement activation |
CA2804926C (en) | 2010-07-09 | 2019-01-08 | James Trinca Green | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
JP6252991B2 (ja) * | 2012-07-04 | 2017-12-27 | 味の素株式会社 | ナファモスタットメシル酸塩の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292429A (en) * | 1978-03-08 | 1981-09-29 | Ciba-Geigy Corporation | Imidazole urea and amido compounds |
AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
JPS57179146A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine compound |
JPS60130561A (ja) * | 1983-12-16 | 1985-07-12 | Torii Yakuhin Kk | アミジン誘導体およびそれを含む強心剤 |
-
1984
- 1984-07-25 JP JP15504584A patent/JPS6133173A/ja active Granted
-
1985
- 1985-07-12 HU HU853727A patent/HU195769B/hu not_active IP Right Cessation
- 1985-07-12 EP EP85903394A patent/EP0190356B1/en not_active Expired - Lifetime
- 1985-07-12 CA CA000486773A patent/CA1254205A/en not_active Expired
- 1985-07-12 WO PCT/JP1985/000392 patent/WO1986000893A1/ja active IP Right Grant
- 1985-07-12 AU AU45492/85A patent/AU567039B2/en not_active Ceased
- 1985-07-12 KR KR1019860700140A patent/KR870001087B1/ko active
- 1985-07-12 DE DE8585903394T patent/DE3582057D1/de not_active Expired - Fee Related
- 1985-07-12 US US06/835,853 patent/US4777182A/en not_active Expired - Fee Related
- 1985-07-23 ES ES545482A patent/ES8607218A1/es not_active Expired
- 1985-07-23 PH PH32559A patent/PH20585A/en unknown
- 1985-07-23 ZA ZA855552A patent/ZA855552B/xx unknown
- 1985-07-23 DD DD85278877A patent/DD235637A5/de not_active IP Right Cessation
- 1985-07-24 CS CS855463A patent/CS255891B2/cs not_active IP Right Cessation
- 1985-07-24 MX MX206081A patent/MX160912A/es unknown
-
1986
- 1986-03-03 DK DK096286A patent/DK169069B1/da not_active IP Right Cessation
- 1986-03-04 FI FI860904A patent/FI78461C/fi not_active IP Right Cessation
- 1986-03-07 NO NO86860865A patent/NO163954C/no not_active IP Right Cessation
- 1986-03-10 KR KR1019860700140A patent/KR860700250A/ko not_active IP Right Cessation
- 1986-03-24 SU SU864027333A patent/SU1456008A3/ru active
-
1988
- 1988-07-11 US US07/217,405 patent/US4820730A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS6133173A (ja) | 1986-02-17 |
NO163954C (no) | 1990-08-15 |
DK169069B1 (da) | 1994-08-08 |
CA1254205A (en) | 1989-05-16 |
US4820730A (en) | 1989-04-11 |
ES8607218A1 (es) | 1986-05-16 |
ES545482A0 (es) | 1986-05-16 |
AU4549285A (en) | 1986-02-25 |
FI78461B (fi) | 1989-04-28 |
EP0190356A4 (en) | 1987-12-09 |
EP0190356B1 (en) | 1991-03-06 |
EP0190356A1 (en) | 1986-08-13 |
MX160912A (es) | 1990-06-14 |
NO163954B (no) | 1990-05-07 |
NO860865L (no) | 1986-04-10 |
AU567039B2 (en) | 1987-11-05 |
FI78461C (fi) | 1989-08-10 |
US4777182A (en) | 1988-10-11 |
FI860904A0 (fi) | 1986-03-04 |
ZA855552B (en) | 1986-03-26 |
DD235637A5 (de) | 1986-05-14 |
WO1986000893A1 (en) | 1986-02-13 |
SU1456008A3 (ru) | 1989-01-30 |
DE3582057D1 (en) | 1991-04-11 |
KR860700250A (ko) | 1986-08-01 |
CS546385A2 (en) | 1987-07-16 |
FI860904A (fi) | 1986-03-04 |
PH20585A (en) | 1987-02-20 |
CS255891B2 (en) | 1988-03-15 |
JPH0461868B2 (da) | 1992-10-02 |
DK96286D0 (da) | 1986-03-03 |
HU195769B (en) | 1988-07-28 |
HUT42433A (en) | 1987-07-28 |
KR870001087B1 (ko) | 1987-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91587I2 (fr) | Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN) | |
ES541557A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro-1,5-benzotiazepina | |
DK96286A (da) | 6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf | |
DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
ES8605506A1 (es) | Procedimiento para preparar derivados de piperidina | |
ES2037098T3 (es) | Procedimiento de preparacion de derivados de la decahidroquinoleina. | |
ES8307760A1 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
ES8306142A1 (es) | "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas". | |
ES508343A0 (es) | "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas". | |
FI812804L (fi) | 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel | |
NO890440L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater. | |
DK391182A (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse | |
FI883483A0 (fi) | Piperidinderivat, deras framstaellning och anvaendning vid terapi. | |
DK422183A (da) | Fremgangsmaade til fremstilling af 5-halogenvinyl-2'-deoxyuridinderivater | |
SE8705196L (sv) | Pyrimidinderivat | |
ES556048A0 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
SE8100122L (sv) | Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa | |
WO1979000941A1 (en) | Pyridazine compounds | |
MC1555A1 (fr) | Dérivés de l'acridanone | |
BG50501A3 (en) | Method for 1, 5- benzthiazepine derivatives production | |
GB1184395A (en) | Substituted Piperazine Derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |